Literature DB >> 21984850

Synthesis of (S)-2-Boc-Amino-8-(R)-(tert-butyldimethylsilanyloxy) decanoic acid, a Precursor to the Unusual Amino Acid Residue of the Anticancer Agent Microsporin B.

Wenxin Gu1, Richard B Silverman.   

Abstract

(S)-2-Boc-Amino-8-(R)-(tert-butyldimethylsilanyloxy) decanoic acid, the Boc-protected precursor of an unusual amino acid residue for the synthesis of microsporin B, was synthesized. The key steps include a Suzuki coupling followed by asymmetric homogeneous hydrogenation.

Entities:  

Year:  2011        PMID: 21984850      PMCID: PMC3185362          DOI: 10.1016/j.tetlet.2011.07.132

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  16 in total

Review 1.  Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.

Authors:  Christina M Grozinger; Stuart L Schreiber
Journal:  Chem Biol       Date:  2002-01

2.  Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents.

Authors:  H Itazaki; K Nagashima; K Sugita; H Yoshida; Y Kawamura; Y Yasuda; K Matsumoto; K Ishii; N Uotani; H Nakai
Journal:  J Antibiot (Tokyo)       Date:  1990-12       Impact factor: 2.649

Review 3.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 4.  Rational design of non-hydroxamate histone deacetylase inhibitors.

Authors:  Takayoshi Suzuki; Naoki Miyata
Journal:  Mini Rev Med Chem       Date:  2006-05       Impact factor: 3.862

Review 5.  Chemistry and biology of chromatin remodeling agents: state of art and future perspectives of HDAC inhibitors.

Authors:  Manuela Rodriquez; Maurizio Aquino; Ines Bruno; Giovanni De Martino; Maurizio Taddei; Luigi Gomez-Paloma
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

6.  [Isolation and structural clarification of chlamydocin].

Authors:  A Closse; R Huguenin
Journal:  Helv Chim Acta       Date:  1974-04-27       Impact factor: 2.164

Review 7.  Histone deacetylase inhibitors as potent modulators of cellular contacts.

Authors:  Mathieu Vinken; Papeleu Peggy; Rogiers Vera; Vanhaecke Tamara
Journal:  Curr Drug Targets       Date:  2006-06       Impact factor: 3.465

8.  Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.

Authors:  S J Darkin-Rattray; A M Gurnett; R W Myers; P M Dulski; T M Crumley; J J Allocco; C Cannova; P T Meinke; S L Colletti; M A Bednarek; S B Singh; M A Goetz; A W Dombrowski; J D Polishook; D M Schmatz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 9.  Chromatin remodeling, cancer and chemotherapy.

Authors:  Pranab Dey
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 10.  Histone deacetylase inhibitors: multifunctional anticancer agents.

Authors:  Tao Liu; Selena Kuljaca; Andrew Tee; Glenn M Marshall
Journal:  Cancer Treat Rev       Date:  2006-03-03       Impact factor: 12.111

View more
  2 in total

Review 1.  A look around the West Indies: The spices of life are secondary metabolites.

Authors:  Adrian Demeritte; William M Wuest
Journal:  Bioorg Med Chem       Date:  2020-10-01       Impact factor: 3.641

Review 2.  Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy.

Authors:  Mariarosaria Conte; Elisabetta Fontana; Angela Nebbioso; Lucia Altucci
Journal:  Mar Drugs       Date:  2020-12-31       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.